Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
10.26
+0.17 (1.68%)
At close: May 12, 2025, 4:00 PM
10.26
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $545.61 million as of May 12, 2025. Its market cap has decreased by -35.08% in one year.
Market Cap
545.61M
Enterprise Value
232.79M
1-Year Change
-35.08%
Ranking
Category
Stock Price
$10.26
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has decreased from $654.64M to $545.61M, a decrease of -16.66%. That is a compound annual growth rate of -4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 536.57M | -26.62% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |